I made four predictions about the stock market in 2024. I thought the S&P 500 would generate positive returns but lower than in 2023. I didn't believe the so- ...

University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

They're calling it "silent" because the wave follows a long period of unusually low COVID activity this fall, so many people ...

The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

In Review 805 articles and counting2,837 new Instagram followers1,771 new Bluesky followers It was quite a year. Join us in ...

The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.